Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance
- 10 June 2011
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 29 (26), 4378-4387
- https://doi.org/10.1016/j.vaccine.2011.04.005
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD®Vaccine, 2010
- Validation of Statistical Signal Detection Procedures in EudraVigilance Post-Authorization DataDrug Safety, 2010
- Monitoring HPV vaccination programmesBMJ, 2010
- Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesThe Lancet, 2010
- ECDC in collaboration with the VAESCO consortium to develop a complementary tool for vaccine safety monitoring in EuropeEurosurveillance, 2009
- Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant VaccineJAMA, 2009
- Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoringVaccine, 2009
- The Epidemiology of Guillain-Barré Syndrome WorldwideNeuroepidemiology, 2008
- Impact of Safety Alerts on Measures of Disproportionality in Spontaneous Reporting DatabasesDrug Safety, 2007
- Data mining for signals in spontaneous reporting databases: proceed with cautionPharmacoepidemiology and Drug Safety, 2006